Clinical study to evaluate the efficacy of shirolepa in dandruff
Not Applicable
Completed
- Conditions
- Health Condition 1: L218- Other seborrheic dermatitis
- Registration Number
- CTRI/2021/05/033424
- Lead Sponsor
- Dr Laxmi M Naik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. All subjects presenting with classical features of Darunaka
2. Aged between 21 years and 60 years
Exclusion Criteria
1] Diseases of scalp other than Darunaka.
2] Diseases of scalp other than Dandruff.
3] Subjects on antibiotics and antimycotics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br/ ><br>1.Kandu <br/ ><br>Grade <br/ ><br>0 No itching <br/ ><br>1 Mild <br/ ><br>2 Moderate <br/ ><br>3 Severe itching <br/ ><br> <br/ ><br>2.Keshabhumi Rukshata <br/ ><br> <br/ ><br>0 No dryness <br/ ><br>1 Mild (dryness with rough skin) <br/ ><br>2 Moderate (dryness with scaling) <br/ ><br>3 Severe (dryness with cracking) <br/ ><br> <br/ ><br>3.Twak Sphutana <br/ ><br> <br/ ><br>0 No scaling <br/ ><br>1 Mild (Scaling less than 1/4th part of scalp) <br/ ><br>2 Moderate (Scaling more than 1/4thpart of scalp) <br/ ><br>3 Severe (Scaling more than 3/4th of scalp) <br/ ><br> <br/ ><br>4.Kesha Chyuti <br/ ><br> <br/ ><br>0 No hairfall <br/ ><br>1 Mild <br/ ><br>2 Moderate <br/ ><br>3 SevereTimepoint: BT- 0th day <br/ ><br>AT- 8th day <br/ ><br>F1- 14th day <br/ ><br>F2- 21st day
- Secondary Outcome Measures
Name Time Method 1.Kandu <br/ ><br>Grade <br/ ><br>0 No itching <br/ ><br>1 Mild <br/ ><br>2 Moderate <br/ ><br>3 Severe itching <br/ ><br>Timepoint: BT- 0th day <br/ ><br>AT- 8th day <br/ ><br>F1- 14th day <br/ ><br>F2- 21st day